Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
300 participants
INTERVENTIONAL
2021-06-28
2022-07-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Thus the principal investigator developed the Évaluation et orientation SOcio-GÉRiatrique (ESOGER) questionnaire available on a secure digital platform enabling both a rapid evaluation and intervention to asses EP needs and provide the adequate ressources. The principal investigator's previous research has demonstrated that ESOGER is one of the rare clinical tools of first contact in telehealth while being global, multidimensional, and equitable.
Hence, the principal investigator hypothesizes that ESOGER is a clinical tool enabling first line care by the Red-Cross to vulnerable EP without a family doctor, which will lead to an improvement in their health, autonomy and quality of life. Moreover, the principal investigator also hypothesizes that for a better deployment, the tool needs to be adapted to Red-Cross' need and EP service providers.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cohort as Part of Undergraduate Medical Studies at the University of Sherbrooke
NCT03928509
Community Intervention to Reduce Social Isolation in Elderly People: a Mixed Methods Multi-approach Evaluation
NCT03142048
Implementation of a Telemedicine Tool in Primary Care for Older Adults
NCT05102890
Establishing Social Connections in Urban Areas: Evaluating a Community-based Programme
NCT06805136
Using Focus Groups to Explore Perceptions of Adults With Low Socioeconomic Status Regarding the NutriQuébec Study
NCT03849846
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group intervention - questionnaire and recommendations
The intervention group will take the ESOGER questionnaire at month 0 and month 3 ( beginning and end) and receive recommendations following their needs.
Recommendations and re-orientation towards appropriate physical, mental, and social health ressources
Resources recommendations and interventions curated to the needs of the EP such as refering them to a social activity for socially isolated EP.
Group control - questionnaire without recommendations
The participants will only take the ESOGER questionnaire at month 0 and month 3 without recommendations.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Recommendations and re-orientation towards appropriate physical, mental, and social health ressources
Resources recommendations and interventions curated to the needs of the EP such as refering them to a social activity for socially isolated EP.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Living at home
* Be registered at the waiting list of GACO at the CIUSSS-Centre-Sud de l'île-de-Montréal (CCSMTL)
Exclusion Criteria
* Participate at another clinical trial, to avoid interferences
* Not understand written or spoken French or English, questionnaires are only available in French and English.
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre integre universitaire de sante et de services sociaux du Centre-Sud-de-l'Île-de-Montréal
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Olivier Beauchet
MD, PhD, Senior researcher, Director of laboratory
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CRIUGM
Montreal, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-1418
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.